Supporting data for: Oxymatrine ameliorates MAFLD via CCMC pathway
Abstract
This entry contains the supporting data for the manuscript titled "Oxymatrine ameliorates metabolic-associated fatty liver disease by targeting the p-MTOR/PIK3CA/LDHB axis in the Central Carbon Metabolism in Cancer pathway". The data are available from the corresponding author upon reasonable request.
Fields of Study & Subjects
Liver Disease Diagnosis and Treatment
Berberine and alkaloids research
Diet
Metabolism
and Disease
Publication details
- Journal / source
- Figshare
- Publication date
- 1 January 2026
- Document type
- Dataset